Bud Genius, Inc. (RIGH)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Bud Genius, Inc. (RIGH) trades at $0.00. Bud Genius, Inc. operates in the cannabis testing and profiling services sector. Market cap: $158,566, Sector: Utilities.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for RIGH: RIGH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates RIGH against Utilities peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
RIGH: 1/1 perspectives are bearish.
How is this calculated? →Bud Genius, Inc. (RIGH) Utility Operations & Dividend Profile
Bud Genius, Inc., operating in the utilities sector, focuses on cannabis testing and profiling services, alongside cloud-based healthcare solutions and celebrity-endorsed product licensing. The company also provides data-driven rating systems for marijuana strains, positioning itself as a multifaceted service provider in the cannabis industry.
What Is the Investment Thesis for RIGH?
Investing in Bud Genius, Inc. (RIGH) presents a high-risk, high-reward scenario. The company's negative P/E ratio of -0.00 and a significantly negative profit margin of -2013.3% indicate substantial losses. The company's beta of -22.83 suggests extreme volatility. Growth catalysts depend on successful market penetration of its cannabis testing services and healthcare solutions. The company's small size and limited resources pose challenges to scaling the business. The investment thesis hinges on the company's ability to achieve profitability and demonstrate sustainable revenue growth in the competitive cannabis and healthcare sectors.
Based on FMP financials and quantitative analysis
RIGH Key Highlights
- Market capitalization of 159K indicates a micro-cap or nano-cap company with limited financial resources.
- Negative P/E ratio of -0.00 reflects the company's lack of profitability.
- Profit margin of -2013.3% highlights significant operational inefficiencies and substantial losses.
- Gross margin of 42.6% suggests potential in the core business activities if operational costs are managed effectively.
- Beta of -22.83 indicates extreme volatility and a negative correlation with the overall market.
Who Are RIGH's Competitors?
RIGH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CGFEF CF Energy Corp. | $0.38 | +31366.67% | $24.88M | 48 |
| CNLPM The Connecticut Light and Power Company | $32.99 | +1.29% | $315.00M | 72 |
| CNTHP The Connecticut Light and Power Company | $52.70 | +0.55% | $318.06M | 69 |
| CNLHP The Connecticut Light and Power Company | $36.95 | +0.00% | $223.00M | 68 |
| CNPWP The Connecticut Light and Power Company | $32.75 | +0.00% | $197.65M | 66 |
| DUKB Duke Energy Corporation 5.625% | $23.42 | +0.52% | $18.21B | 50 |
| SOJD Southern Company (The) Series 2 | $19.35 | +0.36% | $21.66B | 50 |
| TXNM TXNM Energy, Inc. | $56.85 | -0.15% | $6.29B | 50 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RIGH's Key Strengths?
- Diversified service offerings in cannabis and healthcare sectors.
- Proprietary data-driven rating systems.
- Celebrity endorsement network.
- Early mover advantage in niche markets.
What Are RIGH's Weaknesses?
- Small size and limited resources.
- Negative profitability and high losses.
- High beta indicating extreme volatility.
- Limited market presence and brand recognition.
What Could Drive RIGH Stock Higher?
- Potential regulatory changes in cannabis testing standards could increase demand for certified testing services.
- Expansion of cloud-based healthcare solutions into new markets.
- New celebrity endorsement deals boosting product visibility.
- Launch of enhanced data-driven rating system for cannabis strains.
- Strategic partnerships with cannabis retailers.
What Are the Key Risks for RIGH?
- Financial-distress signal — its Altman Z-Score of -4.78 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Intense competition in the cannabis and healthcare sectors.
- Changing regulatory landscape for cannabis.
- Negative profitability and high losses.
- Limited financial resources and small size.
- Economic downturn affecting consumer spending.
What Are the Growth Opportunities for RIGH?
- Expansion of Cannabis Testing Services: The increasing legalization of cannabis in various jurisdictions presents a significant growth opportunity for Bud Genius's testing and profiling services. As more states and countries legalize cannabis, the demand for accurate and reliable testing will increase. The company can capitalize on this trend by expanding its testing capabilities and geographic reach. This market is projected to reach $2.8 billion by 2028, offering substantial revenue potential.
- Development of Cloud-Based Healthcare Solutions: The cloud-based healthcare solutions market is experiencing rapid growth, driven by the increasing adoption of telehealth and remote patient monitoring. Bud Genius can leverage its existing technology to develop and market innovative healthcare solutions that address the needs of caregivers and naturopathy physicians. This market is expected to reach $79.8 billion by 2027, providing a significant growth opportunity.
- Celebrity-Endorsed Product Licensing: Leveraging celebrity endorsements can significantly boost brand awareness and product sales. Bud Genius can expand its licensing services by partnering with more celebrities and developing a wider range of products. This strategy can attract new customers and increase revenue. The global celebrity endorsement market is estimated at $67 billion, offering a significant potential revenue stream.
- Data-Driven Rating Systems for Marijuana Strains: Providing data-driven rating systems for marijuana strains can attract consumers and businesses seeking reliable information about product quality and characteristics. Bud Genius can enhance its rating system by incorporating more data points and user feedback. This can establish the company as a trusted source of information in the cannabis industry. The cannabis analytics market is projected to reach $1.2 billion by 2027.
- Retail Merchandising Services: Offering retail merchandising services can help cannabis retailers optimize their product placement and increase sales. Bud Genius can leverage its expertise in cannabis products to provide valuable merchandising solutions to retailers. This can generate additional revenue and strengthen the company's relationships with key industry players. The retail merchandising services market is estimated at $220 billion.
What Opportunities Does RIGH Have?
- Expansion into new geographic markets.
- Development of innovative healthcare solutions.
- Strategic partnerships with cannabis industry players.
- Increased legalization of cannabis.
What Threats Does RIGH Face?
- Intense competition in cannabis and healthcare sectors.
- Changing regulatory landscape for cannabis.
- Economic downturn affecting consumer spending.
- Technological advancements rendering existing solutions obsolete.
What Are RIGH's Competitive Advantages?
- Proprietary data-driven rating systems for marijuana strains.
- Established relationships with celebrities for product endorsements.
- Early mover advantage in the cannabis testing and profiling market.
What Does RIGH Do?
Bud Genius, Inc., based in Carlsbad, California, operates within the utilities sector, providing cannabis testing and profiling services. The company also offers cloud-based healthcare solutions, enabling real-time health data uploads from smartphones to caregivers and naturopathy physicians. Furthermore, Bud Genius engages in celebrity-endorsed product licensing and retail merchandising services. A key aspect of their business involves providing data-driven rating systems for marijuana strains and cannabis products, aiming to offer consumers and businesses insights into product quality and characteristics. Founded to capitalize on the burgeoning cannabis market, Bud Genius has diversified its services to include healthcare solutions and licensing, attempting to leverage its brand and market presence across multiple sectors. The company's small size, with only 2 employees, suggests an early-stage operation or a business model heavily reliant on outsourcing and partnerships. Its focus on both cannabis-related services and healthcare solutions indicates an attempt to capture synergies between these markets, though the connection may not be immediately apparent to investors.
What Products and Services Does RIGH Offer?
- Provides cannabis testing and profiling services.
- Offers cloud-based healthcare solutions for real-time health data uploads.
- Engages in celebrity-endorsed product licensing.
- Provides retail merchandising services.
- Offers data-driven rating systems for marijuana strains.
- Provides data-driven rating systems for cannabis.
How Does RIGH Make Money?
- Generates revenue through cannabis testing and profiling services.
- Earns income from cloud-based healthcare solutions subscriptions.
- Receives royalties from celebrity-endorsed product licensing agreements.
What Industry Does RIGH Operate In?
Bud Genius, Inc. operates in the evolving cannabis industry, specifically within the testing and profiling services segment. This sector is characterized by increasing regulatory scrutiny and a growing demand for quality assurance. The company also participates in the cloud-based healthcare solutions market, which is experiencing rapid growth due to the increasing adoption of telehealth and remote patient monitoring. Competition includes established testing labs and healthcare technology providers. Bud Genius's success depends on its ability to differentiate its services and establish a strong market presence in these competitive landscapes.
Who Are RIGH's Key Customers?
- Cannabis cultivators and processors requiring testing services.
- Caregivers and naturopathy physicians utilizing cloud-based healthcare solutions.
- Retailers seeking celebrity-endorsed products.
- Consumers seeking data-driven ratings for marijuana strains.
Company Profile
Bud Genius, Inc. operates in the Regulated Electric industry within the Utilities sector. It is headquartered in Carlsbad, US. The company is led by CEO Aaron Stanz. RIGH has traded publicly since 2009.
Bud Genius, Inc. (RIGH) Valuation Context
Valued at 159K, RIGH is classified as a micro-cap stock.
ROE 210%Key Financial Metrics
Return on equity for Bud Genius, Inc. stands at 210.1%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.21 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 3/9Financial Health
Bud Genius, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -4.78 places it in the distress zone, a signal of elevated financial risk.
RIGH Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Diversified service offerings in cannabis and healthcare sectors.
- Proprietary data-driven rating systems.
- Celebrity endorsement network.
- Early mover advantage in niche markets.
Bear Case
- Small size and limited resources.
- Negative profitability and high losses.
- High beta indicating extreme volatility.
- Limited market presence and brand recognition.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
RIGH Latest News
No recent news available for RIGH.
RIGH Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for RIGH.
Price Targets
Wall Street price target analysis for RIGH.
RIGH MoonshotScore
What does this score mean?
The MoonshotScore rates RIGH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Aaron Stanz
CEO
Aaron Stanz serves as the CEO of Bud Genius, Inc., leading a small team of 2 employees. Information on his prior experience is limited, but his current role involves overseeing the company's operations in cannabis testing, healthcare solutions, and product licensing. His leadership is crucial for navigating the company through its early stages and establishing a sustainable business model. His background and expertise in the relevant sectors are not detailed in the provided data.
Track Record: Due to the limited information available, Aaron Stanz's track record at Bud Genius, Inc. cannot be comprehensively assessed. The company's current financial state, characterized by negative profitability and high losses, suggests significant challenges. His strategic decisions and their impact on the company's performance require further evaluation based on future developments and financial results.
RIGH OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Bud Genius, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited information available to investors, and trading activity can be sporadic and less transparent compared to listed exchanges like NYSE or NASDAQ. Investing in companies on the OTC Other tier carries a higher degree of risk due to the potential for limited liquidity and information.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and transparency.
- High risk of fraud or manipulation due to less stringent regulations.
- Significant price volatility and illiquidity.
- Potential for delisting or suspension of trading.
- Limited access to capital and funding opportunities.
- Verify the company's legal status and registration.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Understand the risks associated with investing in OTC securities.
- Consult with a qualified financial advisor.
- Check for any regulatory actions or legal proceedings.
- Verify the company's physical address and contact information.
- Check for independent audits of financial statements (if available).
- Assess the company's website and online presence.
- Look for verifiable customer testimonials or reviews.
- Review press releases and news articles about the company.
RIGH Utilities Stock FAQ
What does Bud Genius, Inc. do?
Bud Genius, Inc. operates within the utilities sector, providing cannabis testing and profiling services, cloud-based healthcare solutions, celebrity-endorsed product licensing, and data-driven rating systems for marijuana strains. The company aims to capitalize on the growing cannabis market and the increasing demand for telehealth solutions by offering a diversified range of services. Its success depends on its ability to effectively integrate these different business lines and establish a strong market presence in each sector.
What do analysts say about RIGH stock?
As of March 17, 2026, there is no available analyst coverage for Bud Genius, Inc. (RIGH). The company's market capitalization of 159K and its OTC Other listing suggest limited institutional interest. Key valuation metrics such as P/E ratio (-0.00) and profit margin (-2013.3%) indicate significant financial challenges. Investors should conduct thorough due diligence and consider the risks associated with investing in micro-cap OTC stocks before making any investment decisions.
What are the main risks for RIGH?
The main risks for Bud Genius, Inc. include intense competition in the cannabis and healthcare sectors, changing regulatory landscape for cannabis, negative profitability and high losses, limited financial resources, and potential economic downturn affecting consumer spending. Additionally, as an OTC-listed company, RIGH faces risks related to limited liquidity, disclosure, and regulatory oversight. The high beta of -22.83 indicates extreme volatility, making it a high-risk investment.
What are the key factors to evaluate for RIGH?
Evaluate RIGH on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does RIGH data refresh on this page?
RIGH prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven RIGH's recent stock price performance?
Bud Genius, Inc. (RIGH) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified service offerings in cannabis and healthcare sectors. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider RIGH overvalued or undervalued right now?
Valuing Bud Genius, Inc. (RIGH) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying RIGH?
Before investing in Bud Genius, Inc. (RIGH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on Bud Genius, Inc.
- Financial data may not be up-to-date.
- OTC market investments are highly speculative.